SPNE - シ―スパイン・ホ―ルディングス (SeaSpine Holdings Corporation) シ―スパイン・ホ―ルディングス

 SPNEのチャート


 SPNEの企業情報

symbol SPNE
会社名 SeaSpine Holdings Corp (シ―スパイン・ホ―ルディングス)
分野(sector) Health Care   ヘルスケア
産業(industry) Medical/Dental Instruments  
業種 医療機器_医療用品_ディストリビュ―タ―   医療関連(Health Care)
概要 事業概要 SeaSpine Holdings Corporation is a medical technology company. The Company is focused on the design development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. The Company operates through the development manufacture and marketing of orthobiologics and spinal fusion hardware segment. It has a portfolio of orthobiologics and spinal fusion hardware solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures in the lumbar thoracic and cervical spine. It offers a portfolio of orthobiologics and spinal fusion hardware products for the treatment of patients suffering from spinal and other orthopedic disorders. Its orthobiologics products consist of a range of bone graft substitutes that are designed to improve bone fusion rates following a range of orthopedic surgeries including spine hip and extremities procedures.   シ―スパイン・ホ―ルディングスは米国の医療テクノロジ―企業。脊髄障害治療のための外科的ソリュ―ションの開発・商業化に従事する。神経外科や脊髄外科の分野で、腰椎、胸椎、頸椎などの脊椎の融合・固定のための製品や技術を米国内外に提供する。本社はカリフォルニア州ビスタ。   SeaSpine (www.seaspine.com) is a global medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. SeaSpine has a comprehensive portfolio of orthobiologics and spinal implants solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures on the lumbar, thoracic and cervical spine. SeaSpine's orthobiologics products consist of a broad range of advanced and traditional bone graft substitutes that are designed to improve bone fusion rates following a wide range of orthopedic surgeries, including spine, hip, and extremities procedures. SeaSpine's spinal implants portfolio consists of an extensive line of products to facilitate spinal fusion in degenerative, minimally invasive surgery (MIS), and complex spinal deformity procedures. Expertise in both orthobiologic sciences and spinal implants product development allows SeaSpine to offer its surgeon customers a differentiated portfolio and a complete solution to meet their fusion requirements. SeaSpine currently markets its products in the United States and in approximately 30 countries worldwide.
本社所在地 5770 Armada Drive Carlsbad CA 92008 USA
代表者氏名 Keith C. Valentine キースC.バレンタイン
代表者役職名 President Chief Executive Officer
電話番号 +1 760-727-8399
設立年月日 42036
市場名 NASDAQ National Market System
ipoyear ―年
従業員数 327人
url www.seaspine.com
nasdaq_url https://www.nasdaq.com/symbol/spne
adr_tso
EBITDA EBITDA(百万ドル) -18.90500
終値(lastsale) 17.8993
時価総額(marketcap) 263889898.9797
時価総額 時価総額(百万ドル) 296.76210
売上高 売上高(百万ドル) 135.30800
企業価値(EV) 企業価値(EV)(百万ドル) 287.49910
当期純利益 当期純利益(百万ドル) -55.53500
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 SeaSpine Holdings Corp revenues increased 5% to $69.6M. Net loss decreased 16% to $14.5M. Revenues reflect United States segment increase of 5% to $62.2M International segment increase of 4% to $7.4M. Lower net loss reflects Research and development decrease of 13% to $5.6M (expense). Basic Earnings per Share excluding Extraordinary Items increased from -$1.46 to -$1.01.

 SPNEのテクニカル分析


 SPNEのニュース

   SeaSpine continues to ride wave following 510k module clearance; shares up ~10%  2021/07/08 18:13:55 Seeking Alpha
   SeaSpine Lauded by Analysts After Spine Module Cleared by FDA  2021/07/08 16:57:38 The Street
The Food and Drug Administrations cleared SeaSpine''s 7D Percutaneous Spine Module for spinal surgery. The company''s shares are higher.
   SeaSpine Stock Is Trading Higher On FDA Approval For 7D Surgical Spine Module  2021/07/08 10:44:09 Benzinga
The FDA has given 510(k) clearance to SeaSpine Holdings Corporation''s (NASDAQ: SPNE ) 7D Percutaneous Spine Module for minimally invasive surgery. This news follows SeaSpine''s recent acquisition of 7D Surgical, a Toronto-based company … Full story available on Benzinga.com
   SeaSpine gets FDA 510k clearance for 7D surgical percutaneous spine module  2021/07/07 20:17:58 Seeking Alpha
   SeaSpine Announces FDA 510(k) Clearance of 7D Surgical Percutaneous Spine Module for Minimally Invasive Surgery  2021/07/07 20:05:00 Intrado Digital Media
CARLSBAD, Calif., July 07, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the FDA 510(k) clearance of its 7D Percutaneous Spine Module for minimally invasive surgery. This represents a new application and increased functionality for its 7D Flash™ Navigation System. This news follows SeaSpine’s recent acquisition of 7D Surgical, a Toronto-based company that develops advanced optical technologies and machine vision-based registration algorithms for surgical navigation to improve patient care. The Company is preparing a limited release of the Percutaneous Spine Module in the third quarter.
   SeaSpine Holdings Stock Is Estimated To Be Significantly Overvalued  2021/06/23 16:00:11 GuruFocus
Related Stocks: SPNE ,
   SeaSpine begins limited commercial launch of the waveform L 3d-printed interbody system  2021/06/08 20:14:52 Seeking Alpha
   SeaSpine Announces Limited Commercial Launch of the WaveForm L (Lateral) 3D-Printed Interbody System  2021/06/08 20:05:00 Wallstreet:Online
CARLSBAD, Calif., June 08, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the limited commercial launch of its 3D-printed WaveForm L (Lateral) Interbody System. WaveForm L is designed for the LLIF (lateral lumbar interbody fusion) procedure, and
   SeaSpine Announces Limited Commercial Launch of the WaveForm® L (Lateral) 3D-Printed Interbody System  2021/06/08 00:00:00 BioSpace
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the limited commercial launch of its 3D-printed WaveForm L (Lateral) Interbody System.
   SeaSpine Reports Granting of Inducement Awards  2021/06/04 20:05:00 Business Insider Markets
CARLSBAD, Calif., June 04, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it has issued
   SeaSpine Earnings Report: Here’s what to expect from Stock market Insights & financial analysis  2021/03/01 18:10:00 Stock Market Daily
SeaSpine announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
   SeaSpine Must-See Earnings Estimates for: Stock market Insights & financial analysis  2021/02/23 20:31:00 Stock Market Daily
SeaSpine announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
   SeaSpine (NASDAQ:SPNE) Earns Buy Rating from Analysts at Stifel Nicolaus  2020/10/23 05:10:42 Stock Observer
Stifel Nicolaus initiated coverage on shares of SeaSpine (NASDAQ:SPNE) in a research note issued to investors on Monday morning, AnalystRatings.net reports. The brokerage issued a buy rating and a $22.00 target price on the medical equipment provider’s stock. Other analysts have also issued reports about the stock. BidaskClub lowered shares of SeaSpine from a buy […]
   Implanet and SeaSpine Announce FDA Clearance of the Mariner Cap System  2020/10/19 15:45:00 Business Wire
BORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans) (Paris:ALIMP), a medical technology company specializing in vertebral and knee-surgery implants, and SeaSpine Holdings Corporation (NASDAQ: SPNE) today announce the clearance of the Mariner Cap System in the United States, which combines SeaSpine’s Mariner® pedicle screw system with Implanet’s unique JAZZ Cap® technology. The ‘Mariner Cap System
   SeaSpine Sales To Beat Estimates; Street Remains Bullish  2020/10/07 06:47:21 Smarter Analyst
SeaSpine Holdings announced preliminary 3Q revenues in the range of $42.9 million to $43. The post SeaSpine Sales To Beat Estimates; Street Remains Bullish appeared first on Smarter Analyst .

 関連キーワード  (医療機器_医療用品_ディストリビュ―タ― 米国株 シ―スパイン・ホ―ルディングス SPNE SeaSpine Holdings Corporation)

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)